Nyingi Kemmer - Concepedia

Author

Nyingi Kemmer

Also Known As

Jacentha Buggs, Kemmer N, Kemmer, Nyingi, Kristina Chacko, Kristina R. Chacko, N Kemmer, N. Kemmer, N.M. Kemmer, Nyingi Kemmer, Nyingi M Kemmer

144

Publications

Citations

H-Index

Concepts

All Affiliations

University of Cincinnati Tampa General Hospital Cincinnati VA Medical Center University of Cincinnati Medical Center University of Pennsylvania

About

Nyingi Kemmer is an author at University of Cincinnati specializing in medicine, hepatology, and liver transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	904
2	Public Health	5	5	172
3	Health Sciences	1	1	30
4	Diabetes	1	1	14
5	Emergency Medicine	1	1	61

Nyingi Kemmer

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension Naga Chalasani, Manal F. Abdelmalek, Guadalupe García–Tsao, Gastroenterology	2019	326
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension Guadalupe García–Tsao, Jaime Bosch, Zeid Kayali, Journal of Hepatology Severe Portal HypertensionHepatologyLiver PhysiologyGastroenterologyPlacebo-controlled Trial	2019	152
Alpha-1-Antitrypsin Deficiency: Outcomes After Liver Transplantation Nyingi Kemmer, Tiffany E. Kaiser, V. Zacharias, Transplantation Proceedings TransplantationAutoimmune DiseaseHepatologyLiver PhysiologyTransplantation Medicine	2008	84
Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinoma Abhishek Mathur, Edson Franco, John P. Leone, HPB ObesityObesity PortendsEarlier RecurrenceHepatologyMedicine	2012	76
Nonalcoholic Fatty Liver Disease Epidemic and Its Implications for Liver Transplantation Nyingi Kemmer, Guy Neff, Edson Franco, Transplantation Solid Organ TransplantationPathologyFatty Liver DiseaseObesityMetabolic Associated Steatotic Liver Disease	2013	68
Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort Miguel Malespin, A. Sidney Barritt, Stephanie Watkins, Clinical Gastroenterology and Hepatology	2021	64
The Role of Coronary Calcium Score in the Risk Assessment of Liver Transplant Candidates Nyingi Kemmer, James A. Case, Shaun Chandna, Transplantation Proceedings Risk AssessmentTransplantationHepatologyCardiovascular DiseaseSolid Organ Transplantation	2014	61
Analysis of Hospitalizations Comparing Rifaximin Versus Lactulose in the Management of Hepatic Encephalopathy Guy Neff, Nyingi Kemmer, V. Zacharias, Transplantation Proceedings Hepatic EncephalopathyHepatologyGastroenterologyAcute Liver FailureMedicine	2006	61
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis Catherine Frenette, Zeid Kayali, Edward Mena, Journal of Hepatology HepatologyLiver PhysiologyGastroenterologyNew DecompensationHepatotoxicity	2020	58
Combination Therapy in Liver Transplant Recipients with Hepatitis B Virus Without Hepatitis B Immune Globulin Guy Neff, Nyingi Kemmer, Tiffany E. Kaiser, Digestive Diseases and Sciences Transplant RejectionTransplantationHepatologyLiver Transplant RecipientsViral Hepatitis	2007	54

Page 1